A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

Oncogene

Volumn 31, Issue 12, 2012, Pages 1558-1570

  Streicher, K L ^a   Zhu, W ^a   Lehmann, K P ^a   Georgantas, R W ^a   Morehouse, C A ^a   Brohawn, P ^a   Carrasco, R A ^a   Xiao, Z ^a   Tice, D A ^a   Higgs, B W ^a   Richman, L ^a   Jallal, B ^a   Ranade, K ^a   Yao, Y ^a  

^a MEDIMMUNE   (United States)

Author keywords

melanocyte transformation; melanoma; miRNA cluster

Indexed keywords

B RAF KINASE; MICRORNA; MICRORNA 506 514; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER INVASION; CELL GROWTH; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOCYTE; MELANOMA; METASTASIS; ONCOGENE; ONCOGENE N RAS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; X CHROMOSOME;

CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; MULTIGENE FAMILY; SKIN NEOPLASMS; UP-REGULATION;

EID: 84860395749     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.345     Document Type: Article

References (39)

1. Ambros V, Lee RC. (2004). Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 265: 131-158.
2. Bandarchi B, Ma L, Navab R, Seth A, Rasty G. (2010). From melanocyte to metastatic malignant melanoma. Dermatol Res Practice 2010: 1-8.
3. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277.
4. Chen J, Feilotter HE, Paré GC, Zhang X, Pemberton JG, Garady C et al. (2010). MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 176: 2520-2529.
5. Chin M, Herscovitch M, Zhang N, Waxman DJ, Gilmore TD. (2009). Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile. Oncogene 28: 2100-2111.
6. Dotto GP. (2008). Notch tumor suppressor function. Oncogene 27: 5115-5123.
7. Dykxhoorn D, Wu Y, Xie H, Yu F, Lal A, Petrocca F et al. (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. Plos One 4: e7181.
8. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M et al. (2008). The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68: 2745-2754. (Pubitemid 351556272)
9. Hartman Z, Yang X, Glass O, Lei G, Osada T, Dave S et al. (2011). HER2 overexpression elicits a pro-inflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis. Cancer Res 71: 4380-4391.
10. Häusler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S et al. (2010). Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103: 693-700.
11. Hoek K, Rimm D, Williams K, Zhao H, Ariyan S, Lin A et al. (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282. (Pubitemid 39006547)
12. Klein W, Wu B, Zhao S, Wu H, Klein-Szanto A, Tahan S. (2007). Increased expression of stem cell markers in malignant melanoma. Mod Path 20: 102-107. (Pubitemid 44967955)
13. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK. (2006). Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25: 5027-5036.
14. Landais S, Landry S, Legault P, Rassart E. (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707. (Pubitemid 46985002)
15. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU et al. (2010). High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10: 262.
16. Li J, Liu Y, Dong D, Zhang Z. (2010). Evolution of an X-linked primate-specific micro RNA cluster. Mol Biol Evol 27: 671-683.
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
18. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH et al. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379. (Pubitemid 352010003)
19. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. (2009). MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 35: 339-347.
20. Monsel G, Ortonne N, Bagot M, Bensussan A, Dumaz N. (2010). C-Kit mutants require hypoxia-inducible factor 1a to transform melanocytes. Oncogene 29: 227-236.
21. Montesano R, Drevon C, Kuroki T, Saint Vincent L, Handleman S, Sanford KK et al. (1977). Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst 59: 1651-1658. (Pubitemid 8255038)
22. Mueller DW, Bosserhoff AK. (2009). Role of miRNAs in the progression of malignant melanoma. Br J Cancer 101: 551-556.
23. Mueller DW, Rehli M, Bosserhoff AK. (2009). miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 29: 1740-1751.
24. Nakamura J, Garcia E, Pieper RO. (2008). S6K1 plays a key role in glial transformation. Cancer Res 68: 6516-6523.
25. Olive V, Jiang I, He L. (2010). mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42: 1348-1354.
26. Osawa M, Fisher DE. (2008). Notch and melanocytes: diverse outcomes from a single signal. J Invest Derm 128: 2571-2574.
27. Palmieri G, Capone M, Ascierto ML, Gentilcore G, Stroncek DF, CasulaMet al. (2009). Main roads to melanoma. J TranslMed 7: 86.
28. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM et al. (2010). Identification of the miR-106bB25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
29. Rasmussen S, Kordon E, Callahan R, Smith GH. (2001). Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene 20: 5291-5301. (Pubitemid 32844061)
30. Rhim JS. (1983). Cell aggregation assay: a rapid means of evaluating and selecting in vitro transformed cells. Cancer Detect Prev 6: 381-388.
31. Rigel DS, Russak J, Friedman R. (2010). The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 60: 301-316.
32. Scholz CC, Berger DP, Winterhalter BR, Henss H, Fiebig HH. (1990). Correlation of drug response in patients and in the clonogenic assay with solid human tumor xenografts. Eur J Cancer 26: 901-905.
33. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. (2008). MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18: 549-557. (Pubitemid 351630945)
34. Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D et al. (2010). Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 16: 1577-1586.
35. Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z. (2009). Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 15: 1443-1461.
36. Syed M, Fenoglio-Preiser C, Skau K, Weber GF. (2008). Acetylcholinesterase supports anchorage independence in colon cancer. Clin Exp Metastasis 25: 787-798.
37. Trainer DL, Kline T, McCabe FL, Faucette LF, Field J, Chaikin M et al. (1988). Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287-296. (Pubitemid 18061157)
38. Zhang R, Peng Y, Wang W, Su B. (2007). Rapid evolution of an X-linked microRNA cluster in primates. Genome Res 17: 612-617. (Pubitemid 46715511)
39. Zirvi KA, Masui H, Giulani FC, Kaplan NO. (1983). Correlation of drug sensitivity on human colon adenocarcinoma cells grown in soft agar and in athymic mice. Int J Cancer 32: 45-51. (Pubitemid 13032535)